Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.

Thompson RN, Phillips JR, McCauley SH, Elliott JR, Moran CG.

J Bone Joint Surg Br. 2012 Mar;94(3):385-90. doi: 10.1302/0301-620X.94B3.27999.

PMID:
22371548
2.

Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.

Nieves JW, Cosman F.

Curr Osteoporos Rep. 2010 Mar;8(1):34-9. doi: 10.1007/s11914-010-0007-2. Review.

PMID:
20425089
3.

What do we know about atypical femoral fractures? Insights and enigmas.

Audran M, Cortet B, Thomas T; Bone division of the French Society for Rheumatology.

Joint Bone Spine. 2011 Dec;78(6):568-71. doi: 10.1016/j.jbspin.2011.03.015. Epub 2011 May 17. Review.

PMID:
21592839
4.

[Atypical femoral fracture associated with the use of bisphosphonates, an adverse drug reaction not to be missed].

Ing Lorenzinit K, Meier R, Suva D, Dayer P, Desmeules J, Peter R.

Rev Med Suisse. 2012 Jun 6;8(344):1238-42. Review. French.

PMID:
22730621
5.

Long-term bisphosphonate usage and subtrochanteric insufficiency fractures: a cause for concern?

Yoon RS, Hwang JS, Beebe KS.

J Bone Joint Surg Br. 2011 Oct;93(10):1289-95. doi: 10.1302/0301-620X.93B10.26924. Review.

PMID:
21969423
6.

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.

Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C.

Osteoporos Int. 2011 Feb;22(2):373-90. doi: 10.1007/s00198-010-1453-5. Epub 2010 Nov 18. Review.

7.

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: sensitivity and trim and fill studies.

Liu J, Zhang HX, Lu XX, Hu JJ, Deng LF.

Genet Test Mol Biomarkers. 2014 Feb;18(2):117-22. doi: 10.1089/gtmb.2013.0331. Epub 2013 Nov 8. Review.

8.

Disentangling the emerging evidence around atypical fractures.

Abrahamsen B, Clark EM.

Curr Rheumatol Rep. 2012 Jun;14(3):212-6. doi: 10.1007/s11926-012-0241-y. Review.

PMID:
22359230
9.
10.

[Femur fractures caused by long-term bisphosphonate therapy].

Somford MP, Thomassen BJ, Draijer WF.

Ned Tijdschr Geneeskd. 2010;154:A1218. Review. Dutch.

PMID:
20619008
11.

Questioning the association between bisphosphonates and atypical femoral fractures.

Pazianas M, Kim SM, Yuen T, Sun L, Epstein S, Zaidi M.

Ann N Y Acad Sci. 2015 Jan;1335:1-9. doi: 10.1111/nyas.12551. Epub 2014 Oct 7. Review.

12.

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.

Gedmintas L, Solomon DH, Kim SC.

J Bone Miner Res. 2013 Aug;28(8):1729-37. doi: 10.1002/jbmr.1893. Review.

13.

Bisphosphonate therapy and atypical fractures.

Saleh A, Hegde VV, Potty AG, Lane JM.

Orthop Clin North Am. 2013 Apr;44(2):137-51. doi: 10.1016/j.ocl.2013.01.001. Epub 2013 Feb 21. Review.

PMID:
23544820
14.

Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?

McClung M.

Clin Obstet Gynecol. 2013 Dec;56(4):743-8. doi: 10.1097/GRF.0b013e3182a98295. Review.

PMID:
24177063
15.

Atypical fractures of the femur related to prolonged treatment with bisphosphonates for osteoporosis.

Rosenthal Y, Arami A, Kosashvili Y, Cohen N, Sidon E, Velkes S.

Isr Med Assoc J. 2014 Feb;16(2):78-82. Review.

16.

Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies.

Giusti A, Hamdy NA, Papapoulos SE.

Bone. 2010 Aug;47(2):169-80. doi: 10.1016/j.bone.2010.05.019. Epub 2010 May 20. Review.

PMID:
20493982
17.

A controversy: linking atypical femoral fractures to bisphosphonate therapy.

Trotter CC, Pfister AK, Whited BA, Goldberg TH, Artz SA.

W V Med J. 2011 Mar-Apr;107(2):8-13. Review.

PMID:
21476471
18.

Increased risk for atypical fractures associated with bisphosphonate use.

Lee S, Yin RV, Hirpara H, Lee NC, Lee A, Llanos S, Phung OJ.

Fam Pract. 2015 Jun;32(3):276-81. doi: 10.1093/fampra/cmu088. Epub 2015 Apr 5. Review.

PMID:
25846215
19.

Atypical femur fractures: a review.

Bronson WH, Kaye ID, Egol KA.

Curr Osteoporos Rep. 2014 Dec;12(4):446-53. doi: 10.1007/s11914-014-0239-7. Review.

PMID:
25287009
20.

Atraumatic bilateral femur fracture in long-term bisphosphonate use.

Goddard MS, Reid KR, Johnston JC, Khanuja HS.

Orthopedics. 2009 Aug;32(8). pii: orthosupersite.com/view.asp?rID=41933. doi: 10.3928/01477447-20090624-27. Review.

PMID:
19708622
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk